{"id":"https://openalex.org/W2164812014","doi":"https://doi.org/10.1371/journal.pone.0025744","title":"Peroral Amphotericin B Polymer Nanoparticles Lead to Comparable or Superior In Vivo Antifungal Activity to That of Intravenous Ambisome\u00ae or Fungizone\u2122","display_name":"Peroral Amphotericin B Polymer Nanoparticles Lead to Comparable or Superior In Vivo Antifungal Activity to That of Intravenous Ambisome\u00ae or Fungizone\u2122","alternate_titles":[],"publication_year":2011,"publication_date":"2011-10-06","ids":{"openalex":"https://openalex.org/W2164812014","doi":"https://doi.org/10.1371/journal.pone.0025744","mag":"2164812014","pmid":"https://pubmed.ncbi.nlm.nih.gov/21998690","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3188565"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0025744","doi":"https://doi.org/10.1371/journal.pone.0025744","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0025744","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0025744&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2164812014"],"child_works_count":6,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0025744&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001147110","display_name":"J. L. Italia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181647926","display_name":"University of Strathclyde","ror":"https://ror.org/00n3w3b69","country_code":"GB","type":"education","lineage":["https://openalex.org/I181647926"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jagdishbhai L. Italia","raw_affiliation_strings":["Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom","institution_ids":["https://openalex.org/I181647926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011598437","display_name":"Joanne Sharp","orcid":"https://orcid.org/0000-0001-8482-5736","observed_orcids":["https://orcid.org/0000-0001-8482-5736"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrew Sharp","raw_affiliation_strings":["School of Translational Medicine, The University of Manchester, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Translational Medicine, The University of Manchester, Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042745349","display_name":"Katharine C. Carter","orcid":"https://orcid.org/0000-0003-2507-1844","observed_orcids":["https://orcid.org/0000-0003-2507-1844"]},"institutions":[{"id":"https://openalex.org/I181647926","display_name":"University of Strathclyde","ror":"https://ror.org/00n3w3b69","country_code":"GB","type":"education","lineage":["https://openalex.org/I181647926"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Katharine C. Carter","raw_affiliation_strings":["Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom","institution_ids":["https://openalex.org/I181647926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078573153","display_name":"Peter A. Warn","orcid":"https://orcid.org/0000-0002-0862-9714","observed_orcids":["https://orcid.org/0000-0002-0862-9714"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Peter Warn","raw_affiliation_strings":["School of Translational Medicine, The University of Manchester, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Translational Medicine, The University of Manchester, Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020267991","display_name":"Majeti N. V. Ravi Kumar","orcid":"https://orcid.org/0000-0001-5606-401X","observed_orcids":["https://orcid.org/0000-0001-5606-401X"]},"institutions":[{"id":"https://openalex.org/I181647926","display_name":"University of Strathclyde","ror":"https://ror.org/00n3w3b69","country_code":"GB","type":"education","lineage":["https://openalex.org/I181647926"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"M. N. V. Ravi Kumar","raw_affiliation_strings":["Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom","institution_ids":["https://openalex.org/I181647926"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5020267991","https://openalex.org/A5078573153"],"corresponding_institution_ids":["https://openalex.org/I181647926","https://openalex.org/I28407311"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":3.9069,"has_fulltext":true,"cited_by_count":70,"citation_normalized_percentile":{"value":0.93159108,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"6","issue":"10","first_page":"e25744","last_page":"e25744"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.6708999872207642,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.6708999872207642,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.22050000727176666,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.07819999754428864,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amphotericin-b","display_name":"amphotericin B","score":0.9940000176429749},{"id":"https://openalex.org/keywords/polymeric-nanoparticles","display_name":"polymeric nanoparticles","score":0.8360000252723694},{"id":"https://openalex.org/keywords/plga-nanoparticles","display_name":"PLGA nanoparticles","score":0.8529999852180481},{"id":"https://openalex.org/keywords/oral-drug-delivery","display_name":"oral drug delivery","score":0.9190000295639038},{"id":"https://openalex.org/keywords/invasive-pulmonary-aspergillosis","display_name":"invasive pulmonary aspergillosis","score":0.9350000023841858},{"id":"https://openalex.org/keywords/disseminated-aspergillosis","display_name":"disseminated aspergillosis","score":0.9929999709129333},{"id":"https://openalex.org/keywords/antifungal-activity","display_name":"antifungal activity","score":0.8799999952316284},{"id":"https://openalex.org/keywords/liposomal-amphotericin-b","display_name":"liposomal amphotericin B","score":0.75},{"id":"https://openalex.org/keywords/fungizone","display_name":"Fungizone","score":0.9739999771118164},{"id":"https://openalex.org/keywords/encapsulation-efficiency","display_name":"encapsulation efficiency","score":0.8259999752044678},{"id":"https://openalex.org/keywords/neutropenic-mice","display_name":"neutropenic mice","score":0.6679999828338623},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.7670000195503235},{"id":"https://openalex.org/keywords/nanoparticle-formulation","display_name":"nanoparticle formulation","score":0.6050000190734863}],"concepts":[{"id":"https://openalex.org/C2779629538","wikidata":"https://www.wikidata.org/wiki/Q412223","display_name":"Amphotericin B","level":3,"score":0.7950170040130615},{"id":"https://openalex.org/C2776391196","wikidata":"https://www.wikidata.org/wiki/Q259626","display_name":"Aspergillosis","level":2,"score":0.74411940574646},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6453089714050293},{"id":"https://openalex.org/C2780165375","wikidata":"https://www.wikidata.org/wiki/Q2102907","display_name":"PLGA","level":3,"score":0.572956383228302},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5100734829902649},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47377657890319824},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.45209720730781555},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4320526123046875},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.361990749835968},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.3184514045715332},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.31290262937545776},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.25233709812164307},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20477470755577087},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16666531562805176},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.11652973294258118},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.0780826210975647},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.07013821601867676}],"mesh":[{"descriptor_ui":"D000096","descriptor_name":"Acetone","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000666","descriptor_name":"Amphotericin B","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000666","descriptor_name":"Amphotericin B","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000666","descriptor_name":"Amphotericin B","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000666","descriptor_name":"Amphotericin B","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004121","descriptor_name":"Dimethyl Sulfoxide","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011108","descriptor_name":"Polymers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D012997","descriptor_name":"Solvents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D055744","descriptor_name":"Invasive Pulmonary Aspergillosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":8,"locations":[{"id":"doi:10.1371/journal.pone.0025744","doi":"https://doi.org/10.1371/journal.pone.0025744","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0025744","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0025744&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2195615","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3188565","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3188565","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3188565/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:21998690","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21998690","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/fde7e2a3-ef0b-4258-b20d-976e6e001d10","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/fde7e2a3-ef0b-4258-b20d-976e6e001d10","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Italia, J L, Sharp, A, Carter, K C, Warn, P & Kumar, M N V R 2011, 'Peroral amphotericin B polymer nanoparticles lead to comparable or superior In Vivo antifungal activity to that of intravenous Ambisome\u00ae or Fungizone\u2122', PLoS ONE, vol. 6, no. 10, e25744. https://doi.org/10.1371/journal.pone.0025744","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:strathprints.strath.ac.uk:36463","doi":null,"is_oa":true,"landing_page_url":"https://strathprints.strath.ac.uk/36463/","pdf_url":"https://strathprints.strath.ac.uk/36463/1/Italia_etal_PLoSOne2011.pdf","source":{"id":"https://openalex.org/S4306402226","display_name":"Strathprints: The University of Strathclyde institutional repository (University of Strathclyde)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I181647926","host_organization_name":"University of Strathclyde","host_organization_lineage":["https://openalex.org/I181647926"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:doaj.org/article:dc7197c92ed84b8f9be94149dd82927b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/dc7197c92ed84b8f9be94149dd82927b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 6, Iss 10, p e25744 (2011)","raw_type":"article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.290.852","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.290.852","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/72/54/PLoS_One_2011_Oct_6_6(10)_e25744.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0025744","doi":"https://doi.org/10.1371/journal.pone.0025744","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0025744","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0025744&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2164812014.pdf","grobid_xml":"https://content.openalex.org/works/W2164812014.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1988456874","https://openalex.org/W1992718131","https://openalex.org/W2014083454","https://openalex.org/W2021055832","https://openalex.org/W2040442835","https://openalex.org/W2045138757","https://openalex.org/W2053454808","https://openalex.org/W2084752824","https://openalex.org/W2095266942","https://openalex.org/W2098493934","https://openalex.org/W2101438344","https://openalex.org/W2105458205","https://openalex.org/W2108627308","https://openalex.org/W2116970793","https://openalex.org/W2125695159","https://openalex.org/W2127708867","https://openalex.org/W2141197648","https://openalex.org/W2143452187","https://openalex.org/W2143733206","https://openalex.org/W2148628183","https://openalex.org/W2151939809","https://openalex.org/W2154318613","https://openalex.org/W2160143310","https://openalex.org/W2167924652","https://openalex.org/W2317628338","https://openalex.org/W4249751692"],"related_works":["https://openalex.org/W2583665135","https://openalex.org/W1980487676","https://openalex.org/W7163815352","https://openalex.org/W2154318613","https://openalex.org/W4244332958","https://openalex.org/W7221098351","https://openalex.org/W2971973725","https://openalex.org/W2018498175"],"abstract_inverted_index":{"BACKGROUND:":[0],"Despite":[1],"advances":[2],"in":[3,19,79,92,101,167],"the":[4,6],"treatment,":[5],"morbidity":[7],"and":[8,107,149,156,188],"mortality":[9],"rate":[10],"associated":[11],"with":[12,28,81,145,185],"invasive":[13,108,177],"aspergillosis":[14,172],"remains":[15],"unacceptably":[16],"high":[17],"(70-90%)":[18],"immunocompromised":[20],"patients.":[21],"Amphotericin":[22],"B":[23],"(AMB),":[24],"a":[25,36],"polyene":[26],"antibiotic":[27],"broad":[29],"spectrum":[30],"antifungal":[31],"activity":[32],"appears":[33],"to":[34,117,183,192],"be":[35,54],"choice":[37],"of":[38,49,89,96,105,119,127,142,170],"treatment":[39,184],"but":[40],"is":[41,181],"available":[42],"only":[43,190],"as":[44,56,58,129,154,158,173,175],"an":[45,50,139,176],"intravenous":[46],"formulation;":[47],"development":[48],"oral":[51,70,97,132,162],"formulation":[52,163],"would":[53],"beneficial":[55],"well":[57,174],"economical.":[59],"METHODOLOGY:":[60],"Poly(lactide-co-glycolode)":[61],"(PLGA)":[62],"nanoparticles":[63],"encapsulating":[64],"AMB":[65,87,147],"(AMB-NPs)":[66],"were":[67,74],"developed":[68,161],"for":[69,131],"administration.":[71],"The":[72,91,135,160],"AMB-NPs":[73,98,111,144],"113":[75],"\u00b1":[76],"20":[77],"nm":[78],"size":[80],"~70%":[82],"entrapment":[83,150],"efficiency":[84,151],"at":[85],"30%":[86],"w/w":[88],"polymer.":[90],"vivo":[93],"therapeutic":[94],"efficacy":[95,116],"was":[99,164],"evaluated":[100],"neutropenic":[102],"murine":[103,168],"models":[104,169],"disseminated":[106,171],"pulmonary":[109,178],"aspergillosis.":[110],"exhibited":[112],"comparable":[113],"or":[114,121],"superior":[115],"that":[118],"Ambisome\u00ae":[120],"Fungizone\u2122":[122,187],"administered":[123],"parenterally":[124],"indicating":[125],"potential":[126],"NPs":[128],"carrier":[130],"delivery.":[133],"CONCLUSIONS:":[134],"present":[136],"investigation":[137],"describes":[138],"efficient":[140],"way":[141],"producing":[143],"higher":[146],"pay-load":[148],"employing":[152],"DMSO":[153],"solvent":[155],"ethanol":[157],"non-solvent.":[159],"highly":[165],"efficacious":[166],"aspergillosis,":[179],"which":[180],"refractory":[182],"IP":[186],"responds":[189],"modestly":[191],"AmBisome\u00ae.":[193]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2164812014","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
